SOURCE: Bio-Rad Laboratories

July 05, 2011 08:30 ET

Bio-Rad Riders Help Raise $1.5 Million During the Napa Valley Tour de Cure

HERCULES, CA--(Marketwire - Jul 5, 2011) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, helped raise funds with other teams and riders that totaled over $1.5 million during the 20th annual Napa Valley Tour de Cure, which took place on May 1 to benefit the American Diabetes Association.

This year Bio-Rad was the presenting sponsor of the Tour de Cure in Napa Valley and produced one of the event's largest teams with nearly 180 riders. The Bio-Rad team raised over $84,000, exceeding last year and setting a new company record. Bio-Rad also participates in Tour de Cure events in other locations throughout the U.S.

"It is wonderful to see such support and participation from Bio-Rad for the Tour de Cure each year," said Bio-Rad President and CEO Norman Schwartz. "I would like to recognize all of the participants for their efforts in making the Napa Valley Tour de Cure such a success. Events such as these give us all the opportunity to help improve the lives of those living with this disease."

Tour de Cure is a series of cycling events held across the nation at various times each year.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The Company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The Company employs over 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, visit

Contact Information

  • For more information, please contact:
    Bio-Rad Laboratories, Inc.
    Tina Cuccia
    Corporate Communications
    Email Contact